<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">41930</article-id><article-id pub-id-type="doi">10.7554/eLife.41930</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-121707"><name><surname>Langer</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121708"><name><surname>Hammer</surname><given-names>Christian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4548-7548</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121709"><name><surname>Hopfensperger</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121717"><name><surname>Klein</surname><given-names>Lukas</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121710"><name><surname>Hotter</surname><given-names>Dominik</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121716"><name><surname>De Jesus</surname><given-names>Paul D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121714"><name><surname>Herbert</surname><given-names>Kristina M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121711"><name><surname>Pache</surname><given-names>Lars</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121712"><name><surname>Smith</surname><given-names>Nikaïa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121713"><name><surname>van der Merwe</surname><given-names>Johannes A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121715"><name><surname>Chanda</surname><given-names>Sumit K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4798"><name><surname>Fellay</surname><given-names>Jacques</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8240-939X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21373"><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-121281"><name><surname>Sauter</surname><given-names>Daniel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7665-0040</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Infectious and Inflammatory Disease Center</institution>, <institution>Sanford Burnham Prebys Medical Discovery Institute</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">School of Life Sciences</institution>, <institution>École Polytechnique Fédérale de Lausanne</institution>, <addr-line><named-content content-type="city">Lausanne</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff3"><institution content-type="dept">Institute of Molecular Virology</institution>, <institution>Ulm University Medical Center</institution>, <addr-line><named-content content-type="city">Ulm</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-70124"><name><surname>Simon</surname><given-names>Viviana</given-names></name><role>Reviewing editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>daniel.sauter@uni-ulm.de</email> (DS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>02</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e41930</elocation-id><history><date date-type="received"><day>11</day><month>09</month><year>2018</year></date><date date-type="accepted"><day>26</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Langer et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Langer et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-41930-v1.pdf"/><abstract><p>Many viral pathogens target innate sensing cascades and/or cellular transcription factors to suppress antiviral immune responses. Here, we show that the accessory viral protein U (Vpu) of HIV-1 exerts broad immunosuppressive effects by inhibiting activation of the transcription factor NF-κB. Global transcriptional profiling of infected CD4+ T-cells revealed that <italic>vpu</italic>-deficient HIV-1 strains induce substantially stronger immune responses than the respective wild type viruses. Gene set enrichment analyses and cytokine arrays showed that Vpu suppresses the expression of NF-κB targets including interferons and restriction factors. Mutational analyses demonstrated that this immunosuppressive activity of Vpu is independent of its ability to counteract the restriction factor and innate sensor tetherin. However, Vpu-mediated inhibition of immune activation required an arginine residue in the cytoplasmic domain that is critical for blocking NF-κB signaling downstream of tetherin. In summary, our findings demonstrate that HIV-1 Vpu potently suppresses NF-κB-elicited antiviral immune responses at the transcriptional level.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SPP 1923</award-id><principal-award-recipient><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name><name><surname>Sauter</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>European Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>International Graduate School in Molecular Medicine Ulm</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Langer</surname><given-names>Simon</given-names></name><name><surname>Hopfensperger</surname><given-names>Kristina</given-names></name><name><surname>Hotter</surname><given-names>Dominik</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>404687549</award-id><principal-award-recipient><name><surname>Langer</surname><given-names>Simon</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The use of human PBMCs was approved by the Ethics Committee of the Ulm University Medical Center (application #50/16). All donors were anonymized and provided informed written consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>RNA sequencing data have been uploaded to the Gene Expression Omnibus (GEO) database (accession number #GSE117655).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Langer S</collab><collab>Hammer C</collab><collab>De Jesus PD</collab><collab>Herbert KM</collab><collab>Pache L</collab><collab>Chanda SK</collab><collab>Fellay J</collab><collab>Sauter D</collab></person-group><year iso-8601-date="2018">2018</year><source>HIV-1 Vpu exerts broad immunosuppressive effects by inhibiting NF-κB-dependent gene expression</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117655">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE117655</ext-link><comment>NCBI Gene Expression Omnibus, GSE117655</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-41930-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>